$1.5116
0.1916[14.52%]
At close: Apr 24
$1.38
-0.1316[-8.71%]
After Hours: 9:28AM EDT
Enlivex Therapeutics
(NASDAQ:ENLV)Latest News for Enlivex Therapeutics Stock (NASDAQ:ENLV)
Enlivex Therapeutics Stock (NASDAQ: ENLV)
Categories: All
Tuesday, April 23, 2024
Monday, April 22, 2024
Tuesday, April 16, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
- Nasdaq Jumps 250 Points; Crude Oil Down 1%Avi Kapoor - Apr 11, 2024, 3:21PM
- Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 11, 2024, 1:33PM
- Dow Dips 100 Points; CarMax Earnings Miss ViewsAvi Kapoor - Apr 11, 2024, 11:55AM
- Nasdaq Gains Over 50 Points; US Producer Prices Increase In MarchAvi Kapoor - Apr 11, 2024, 9:41AM
- Enlivex shares are trading lower. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.Benzinga Newsdesk - Apr 11, 2024, 9:08AM
- Enlivex Announces Topline Results Of Its Phase II Trial Evaluating Allocetra In Patients With SepsisBenzinga Newsdesk - Apr 11, 2024, 8:18AM
Monday, February 26, 2024
Wednesday, February 21, 2024
Wednesday, February 07, 2024
Wednesday, January 17, 2024
Tuesday, December 26, 2023
Friday, December 22, 2023
Wednesday, December 20, 2023
- Enlivex Therapeutics shares are trading higher after the company announced that it completed enrollment of all 120 patients in its Phase II trial of Allocetra in patients with sepsis.Benzinga Newsdesk - Dec 20, 2023, 11:58AM
- Enlivex Therapeutics Announced That The Company Completed Enrollment Of All 120 Patients In Its Phase II Trial Of Allocetra In Patients With SepsisBenzinga Newsdesk - Dec 20, 2023, 8:10AM